# Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging

> **NCT03354611** · PHASE2,PHASE3 · TERMINATED · sponsor: **Koning Corporation** · enrollment: 21 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** Contrast Enhanced Cone Beam Breast CT Scan
- **DRUG:** Contrast Dye, Iodinated

## Key facts

- **NCT ID:** NCT03354611
- **Lead sponsor:** Koning Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-09-10
- **Primary completion:** 2021-09-01
- **Final completion:** 2021-09-01
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** The study progress doesn't meet the sponsor's requirement
- **Last updated:** 2023-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03354611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03354611, "Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03354611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*